2 results
Approved WMORecruiting
Study CA001-050 is a Phase 2 randomized, open label, multicenter clinical study designed to assess the safety and tolerability, of treatment with MS-986012 in combination with chemotherapy (carboplatin and etoposide) and nivolumab when administered…
Approved WMOPending
To evaluate whether cue-induced nicotine craving and cognitive control in smoking individuals can be modulated with cTBS at left or right insula using deep TMS.